We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Urban Outfitters
URBN
$6.75B
| $9.14K | ﹤0.01% |
126
-565
| -82% | -$33.9K |
|
|
UCTT
1827
Ultra Clean Holdings
UCTT
$3.38B
| $9.03K | ﹤0.01% |
400
-58,070
| -99% | -$1.19M |
|
1828
iShares MSCI Japan ETF
EWJ
$22.7B
| $9K | ﹤0.01% |
120
| – | – |
|
|
IGMS
1829
DELISTED
IGM Biosciences
IGMS
| $8.94K | ﹤0.01% |
7,981
+1,959
| +33% | +$2.39K |
|
1830
Climb Global Solutions
CLMB
$542M
| $8.87K | ﹤0.01% |
332
| – | – |
|
1831
Addus HomeCare
ADUS
$2.2B
| $8.87K | ﹤0.01% |
77
-38
| -33% | -$4.11K |
|
1832
Clearfield
CLFD
$407M
| $8.81K | ﹤0.01% |
203
-10,710
| -98% | -$367K |
|
|
FFWM
1833
DELISTED
First Foundation Inc
FFWM
| $8.79K | ﹤0.01% |
1,723
-72
| -4% | -$369 |
|
1834
Priority Technology Holdings
PRTH
$446M
| $8.71K | ﹤0.01% |
1,119
+495
| +79% | +$3.72K |
|
1835
Ooma
OOMA
$633M
| $8.55K | ﹤0.01% |
663
-34
| -5% | -$433 |
|
1836
Vaxcyte
PCVX
$9.1B
| $8.48K | ﹤0.01% |
+261
| New | +$8.56K |
|
1837
F&G Annuities & Life
FG
$3.09B
| $8.47K | ﹤0.01% |
265
-109
| -29% | -$3.62K |
|
|
BTM
1838
DELISTED
Bitcoin Depot
BTM
| $8.45K | ﹤0.01% |
+238
| New | +$5.06K |
|
1839
Domo
DOMO
$184M
| $8.45K | ﹤0.01% |
+605
| New | +$6.09K |
|
|
MITT
1840
TPG Mortgage Investment Trust
MITT
$212M
| $8.43K | ﹤0.01% |
1,117
-1,579
| -59% | -$10.9K |
|
1841
Porch Group
PRCH
$1.98B
| $8.41K | ﹤0.01% |
713
+638
| +851% | +$5.48K |
|
|
MODV
1842
DELISTED
ModivCare
MODV
| $8.32K | ﹤0.01% |
2,668
-305
| -10% | -$561 |
|
1843
Alkami Technology
ALKT
$2.18B
| $8.29K | ﹤0.01% |
275
-162,769
| -100% | -$4.52M |
|
1844
Centrus Energy
LEU
$3.89B
| $8.24K | ﹤0.01% |
+45
| New | +$4.8K |
|
1845
Ibotta
IBTA
$734M
| $8.2K | ﹤0.01% |
224
-6,516
| -97% | -$304K |
|
|
SRTA
1846
Strata Critical Medical Inc
SRTA
$546M
| $7.91K | ﹤0.01% |
+1,963
| New | +$6.39K |
|
1847
Perimeter Solutions
PRM
$5.24B
| $7.91K | ﹤0.01% |
568
-267
| -32% | -$3.08K |
|
1848
Corbus Pharmaceuticals
CRBP
$215M
| $7.8K | ﹤0.01% |
1,130
+1,066
| +1,666% | +$7.74K |
|
1849
Larimar Therapeutics
LRMR
$421M
| $7.67K | ﹤0.01% |
+2,655
| New | +$6.15K |
|
1850
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$265M
| $7.63K | ﹤0.01% |
183
| – | – |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.